ASH announces new executive committee members
Four individuals have been elected to American Society of Hematology’s executive committee.
Belinda R. Avalos, MD, will serve a 1-year term as vice president, followed by successive terms as president-elect and president.
Joseph Mikhael, MD, MEd, will serve a 4-year term as treasurer.
Christopher R. Flowers, MD, MSc, and Charlotte M. Niemeyer, MD, MA, will serve 4-year terms as councilors.
Their terms will begin after this year’s ASH Annual Meeting, scheduled for Dec. 10-13 in New Orleans.
“Drs. Avalos, Mikhael, Flowers and Niemeyer have demonstrated immense dedication to ASH, its members and the field of hematology. Together, they represent the future of the society and the field. I want to congratulate them on the results of the election, and I look forward to their contributions to the society,” ASH President Jane N. Winter, MD, professor of medicine in the division of hematology/oncology at Northwestern University’s Feinberg School of Medicine and member of Robert H. Lurie Comprehensive Cancer Center, said in a society-issued press release. “Under their leadership, the society will be well-positioned to lead our field in education, cutting-edge research and advocacy on behalf of patients with blood disorders worldwide.”
Avalos, professor of medicine and a senior adviser to the president of Atrium Health Levine Cancer Institute, has made significant research contributions in the areas of leukemogenesis, congenital neutropenia, transplantation and cellular therapy.
Mikhael is professor in the applied cancer research and drug discovery division at the Translational Genomics Research Institute (TGen), an affiliate of City of Hope, and chair of the diversity, equity and inclusion council at TGen. His research interests include multiple myeloma, health disparities, education and health communications.
Flowers is division head ad interim of the division of cancer medicine and chair of the department of lymphoma and myeloma at The University of Texas MD Anderson Cancer Center. His research interests include clinical lymphoma; evidence-based clinical practice guidelines development; and epidemiologic, translational and outcomes research studies.
Niemeyer is professor of pediatrics and director of the division of pediatric hematology and oncology in the department of pediatrics at Freiburg University Medical Center. Her research interests include diagnosis of and therapy for bone marrow failure disorders, pediatric myelodysplastic syndrome and juvenile myelomonocytic leukemia.
Read more about